BindingDB logo
myBDB logout

BDBM354186 (R)-5-(2-(5-fluoro-2- methoxypyridin-3-yl)pyrrolidin-1- yl)-N-(3- hydroxypropyl)pyrazolo[l,5- a]pyrimidine-3-carboxamide::US9796724, Example 148

SMILES: COc1ncc(F)cc1C1CCCN1c1ccn2ncc(C(=O)NCCCO)c2n1

InChI Key: InChIKey=VTUVGNKQBUVKIW-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 354186   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
JAK2 (aa 808-1132)


(Homo sapiens (Human))
BDBM354186
PNG
((R)-5-(2-(5-fluoro-2- methoxypyridin-3-yl)pyrrolid...)
Show SMILES COc1ncc(F)cc1C1CCCN1c1ccn2ncc(C(=O)NCCCO)c2n1
Show InChI InChI=1S/C20H23FN6O3/c1-30-20-14(10-13(21)11-23-20)16-4-2-7-26(16)17-5-8-27-18(25-17)15(12-24-27)19(29)22-6-3-9-28/h5,8,10-12,16,28H,2-4,6-7,9H2,1H3,(H,22,29)
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+3n/an/an/an/an/an/a



Array BioPharma, Inc.

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US9796724 (2017)


BindingDB Entry DOI: 10.7270/Q27M0B21
More data for this
Ligand-Target Pair
High affinity nerve growth factor receptor


(Homo sapiens (Human))
BDBM354186
PNG
((R)-5-(2-(5-fluoro-2- methoxypyridin-3-yl)pyrrolid...)
Show SMILES COc1ncc(F)cc1C1CCCN1c1ccn2ncc(C(=O)NCCCO)c2n1
Show InChI InChI=1S/C20H23FN6O3/c1-30-20-14(10-13(21)11-23-20)16-4-2-7-26(16)17-5-8-27-18(25-17)15(12-24-27)19(29)22-6-3-9-28/h5,8,10-12,16,28H,2-4,6-7,9H2,1H3,(H,22,29)
PDB
MMDB

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.10n/an/an/an/an/an/a



Array BioPharma, Inc.

US Patent


Assay Description
Trk enzymatic selectivity was assessed using Omnia™ Kinase Assay reagents from Invitrogen Corp. Enzyme (either TrkA or TrkB from Invitrogen Corp.) an...


US Patent US9796724 (2017)


BindingDB Entry DOI: 10.7270/Q27M0B21
More data for this
Ligand-Target Pair